APRETERO CAPSULES KIT

About

APRETERO CAPSULES KIT contains Aprepitant, a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. This medication works by blocking the action of substance P, a neuropeptide involved in the transmission of nausea and vomiting signals in the brain. It is primarily used in combination with other antiemetics to prevent both acute and delayed chemotherapy-induced nausea and vomiting (CINV).

Aprepitant's unique mechanism of action targets a different pathway than traditional antiemetics like 5-HT3 receptor antagonists and corticosteroids, making it highly effective when used as part of a multi-drug regimen. It significantly improves the control of nausea and vomiting, particularly the delayed phase of CINV, which can be challenging to manage. Its oral formulation provides convenience for patients undergoing chemotherapy.

Uses

• Prevention of acute chemotherapy-induced nausea and vomiting.
• Prevention of delayed chemotherapy-induced nausea and vomiting.
• Used in combination with a 5-HT3 antagonist and a corticosteroid.
• For highly and moderately emetogenic chemotherapy regimens.

Directions For Use

Take the capsules orally as directed by your physician, usually starting before chemotherapy. Follow the specific dosing schedule provided in the kit.

Benefits

• Highly effective in preventing both acute and delayed CINV.
• Targets a distinct pathway (NK1 receptor) for antiemetic action.
• Significantly improves control of nausea and vomiting.
• Enhances the efficacy of other antiemetic medications.
• Improves patient comfort and quality of life during chemotherapy.
• Oral formulation offers convenience for patients.

Side Effects

• Fatigue
• Hiccups
• Constipation
• Diarrhea
• Headache
• Dizziness
• Anorexia
• Dyspepsia (indigestion)
• Abdominal pain
• Neutropenia
• Asthenia (weakness)
• Elevated liver enzymes

Safety Measures

• Alcohol - No specific interaction with alcohol is known, but alcohol can exacerbate nausea and vomiting, so it's best to avoid it.
• Pregnancy - Use only if clearly needed. Animal studies show no direct harmful effects, but human data are limited. Consult your doctor.
• Breastfeeding - It is unknown if Aprepitant is excreted in human milk. Caution should be exercised, and a doctor's advice sought.
• Liver - Use with caution in patients with severe hepatic impairment. Dose adjustment may be necessary.
• Kidney - No dose adjustment is typically required for renal impairment.
• Lung - No specific lung-related precautions are generally needed.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.